Moelis & Company (NYSE:MC) Price Target Raised to $89.00

Moelis & Company (NYSE:MC) had its target price lifted by Morgan Stanley from $86.00 to $89.00 in a research note published on Tuesday morning,Benzinga reports. Morgan Stanley currently has an overweight rating on the asset manager’s stock.

Several other equities analysts have also commented on the stock. Keefe, Bruyette & Woods lowered shares of Moelis & Company from an “outperform” rating to a “market perform” rating and increased their price objective for the company from $78.00 to $80.00 in a research report on Tuesday, December 16th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Moelis & Company in a report on Monday, December 29th. Deutsche Bank Aktiengesellschaft started coverage on Moelis & Company in a research note on Thursday, October 9th. They set a “buy” rating and a $80.00 price objective on the stock. UBS Group started coverage on Moelis & Company in a research note on Thursday, December 11th. They issued a “neutral” rating and a $70.00 price objective for the company. Finally, BMO Capital Markets assumed coverage on Moelis & Company in a research report on Friday, October 3rd. They set a “market perform” rating and a $74.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $72.00.

Moelis & Company Trading Down 0.2%

Shares of Moelis & Company stock opened at $74.41 on Tuesday. The stock has a 50 day moving average of $67.06 and a 200 day moving average of $68.92. Moelis & Company has a 12 month low of $47.00 and a 12 month high of $82.89. The firm has a market cap of $5.83 billion, a PE ratio of 24.89, a PEG ratio of 0.60 and a beta of 1.85.

Moelis & Company (NYSE:MC) last released its quarterly earnings data on Wednesday, October 29th. The asset manager reported $0.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.57 by $0.11. The business had revenue of $356.89 million for the quarter, compared to the consensus estimate of $336.14 million. Moelis & Company had a return on equity of 45.62% and a net margin of 15.98%.The company’s revenue was up 30.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.22 EPS. As a group, equities research analysts forecast that Moelis & Company will post 2.97 earnings per share for the current fiscal year.

Moelis & Company Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, December 4th. Shareholders of record on Monday, November 10th were given a $0.65 dividend. This represents a $2.60 annualized dividend and a yield of 3.5%. The ex-dividend date was Monday, November 10th. Moelis & Company’s dividend payout ratio is currently 86.96%.

Hedge Funds Weigh In On Moelis & Company

Several large investors have recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC grew its position in Moelis & Company by 7.6% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 381,458 shares of the asset manager’s stock valued at $26,221,000 after buying an additional 26,800 shares during the period. New England Research & Management Inc. boosted its stake in shares of Moelis & Company by 10.6% during the 4th quarter. New England Research & Management Inc. now owns 6,000 shares of the asset manager’s stock worth $412,000 after acquiring an additional 575 shares in the last quarter. Tudor Investment Corp ET AL acquired a new stake in shares of Moelis & Company during the 3rd quarter valued at about $5,718,000. Allworth Financial LP grew its position in shares of Moelis & Company by 153.9% during the 3rd quarter. Allworth Financial LP now owns 419 shares of the asset manager’s stock valued at $30,000 after acquiring an additional 254 shares during the period. Finally, Swiss Life Asset Management Ltd purchased a new position in shares of Moelis & Company in the 3rd quarter valued at about $244,000. 91.53% of the stock is currently owned by institutional investors and hedge funds.

Key Headlines Impacting Moelis & Company

Here are the key news stories impacting Moelis & Company this week:

• Positive Sentiment: Zacks Research raised several near?term and forward EPS forecasts for MC (small bumps to Q4?2025, Q2?2026, Q4?2026, Q1/Q2?2027 and FY2025–FY2027, with FY2027 raised to $4.38), signaling improved earnings outlook from that shop; Zacks still carries a “Hold” rating. MarketBeat Zacks Note
• Positive Sentiment: Morgan Stanley lifted its price target on MC to $89, a notably higher target that could support upside if other investors follow suit. Morgan Stanley Price Target Raise
• Neutral Sentiment: UBS raised its price target to $74 but kept a “neutral” rating — a modest signal that trims downside risk but does not constitute an outright bullish endorsement. Benzinga UBS Note

About Moelis & Company

Moelis & Co operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments. The company was founded by Kenneth David Moelis, Navid Mahmoodzadegan, Jeffrey Raich and Elizabeth Ann Crain in July 2007 and is headquartered in New York, NY.